Related Experiment Videos
Myocardial contrast echocardiography in acute myocardial infarction
1Cardiovascular Institute, University of Pittsburgh, Pennsylvania 15213, USA. villanuevafs@msx.upmc.edu
Insights
Myocardial contrast echocardiography (MCE) assesses microvascular blood flow after acute myocardial infarction (AMI). It helps predict tissue damage and recovery, guiding treatment for heart attack patients.
Area of Science:
- Cardiology
- Medical Imaging
- Physiology
Background:
- Acute myocardial infarction (AMI) requires restoring blood flow to prevent heart muscle damage.
- Epicardial artery patency after AMI does not guarantee microvascular flow, leading to the no-reflow phenomenon.
- No-reflow, or microvascular dysfunction, correlates with infarct size and impacts myocardial salvage.
Purpose of the Study:
- To evaluate the utility of Myocardial Contrast Echocardiography (MCE) in assessing microvascular reflow after reperfused AMI.
- To determine if MCE findings predict myocardial salvage, ventricular function recovery, and complications post-AMI.
Main Methods:
- Myocardial Contrast Echocardiography (MCE) was employed to interrogate intramyocardial microvasculature.
- MCE was used both during acute coronary occlusion and after reperfusion to assess the area at risk and reflow patterns.
Main Results:
- MCE patterns of microvascular reflow are predictive of myocardial salvage and the extent of necrosis.
- MCE findings correlate with the recovery of ventricular function and the likelihood of post-AMI complications.
- MCE can delineate the area at risk during coronary occlusion and assess collateral blood flow.
Conclusions:
- MCE is a valuable tool for assessing microvascular function in acute myocardial infarction.
- MCE provides crucial information for predicting outcomes, including ventricular function, remodeling, and complications.
- The technique offers multiple clinically relevant applications in the management of AMI.
Abstract:
During acute myocardial infarction (AMI), the immediate therapeutic goal is to establish patency of the infarct-related artery. The restoration of epicardial coronary artery patency, however, is not equivalent to restoration of nutritive tissue flow. Functional and structural microvascular disruption (no-reflow phenomenon), despite infarct artery patency, is an important pathophysiologic phenomenon in the setting of reperfused AMI. Because the extent of no-reflow parallels the extent of necrosis, its identification is valuable in predicting the degree of myocardial salvage after treatment for AMI. Myocardial contrast echocardiography (MCE) principally interrogates the intramyocardial microvasculature and is thus ideally suited for assessing microvascular reflow after acute infarct reperfusion. MCE reperfusion patterns are predictive of the extent of recovery of ventricular function, complications after AMI, ventricular remodeling, and coronary flow reserve impairments. Furthermore, MCE during acute coronary occlusion delineates the area at risk for necrosis and extent of collateral blood flow. MCE thus has multiple clinically useful applications in the setting of AMI.